No strong hereditary syndromes have been linked to uterine adenosarcoma, but alterations in TP53 and DNA repair–related genes, such as ATM, may guide individualized therapy in advanced or recurrent disease. Here, TP53 is linked to uterine corpus adenosarcoma.